These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8307613)

  • 1. Heterogeneity amongst natural killer cells revealed by limiting dilution culture; selectivity against virus-infected and tumour cell targets.
    Mason PD; Sissons JG; Borysiewicz LK
    Immunology; 1993 Dec; 80(4):625-32. PubMed ID: 8307613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon.
    Canessa A; Chatterjee S; Whitley RJ; Prasthofer EF; Grossi CE; Tilden AB
    Viral Immunol; 1990; 3(3):217-24. PubMed ID: 1701642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic origin of some natural killer cells: clonal proliferation of human CD3-16+ cells from CD3-4-8- thymocyte precursors requires the presence of H9 leukemic cells.
    Mingari MC; Poggi A; Bellomo R; Pella N; Moretta L
    Int J Clin Lab Res; 1991; 21(2):176-8. PubMed ID: 1840028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
    Howell DM; Fitzgerald-Bocarsly P
    Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional analysis of human CD3- decidual leucocyte clones.
    Christmas SE; Bulmer JN; Meager A; Johnson PM
    Immunology; 1990 Oct; 71(2):182-9. PubMed ID: 2146213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
    Rayner AA; Grimm EA; Lotze MT; Wilson DJ; Rosenberg SA
    J Natl Cancer Inst; 1985 Jul; 75(1):67-75. PubMed ID: 2989604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
    Chang WC; Hsiao MH; Pattengale PK
    Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective NK cell activity following thermal injury.
    Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
    Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
    Miescher S; Whiteside TL; Moretta L; von Fliedner V
    J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limiting dilution analysis (LDA) of cells responding to recombinant interleukin-2 without previous stimulation: evidence that all responding cells are lymphokine-activated potent effectors.
    Vie H; Bonneville M; Sondermeyer P; Moreau JF; Soulillou JP
    Immunology; 1986 Mar; 57(3):351-7. PubMed ID: 3082744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor.
    Bolhuis RL; Roozemond RC; van de Griend RJ
    J Immunol; 1986 Jun; 136(11):3939-44. PubMed ID: 3084649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A
    J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and functional cellular differences between human CD3- decidual and peripheral blood leukocytes.
    Deniz G; Christmas SE; Brew R; Johnson PM
    J Immunol; 1994 May; 152(9):4255-61. PubMed ID: 8157952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal analysis of human CD4-CD8-CD3- thymocytes highly purified from postnatal thymus.
    Hori T; Spits H
    J Immunol; 1991 Apr; 146(7):2116-21. PubMed ID: 1826017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversibility of lymphokine-induced NK-like activity in virus-specific cytotoxic T-lymphocyte clones.
    Ronchese F; Collavo D; Zanovello P; Cerundolo V; Biasi G
    Immunology; 1985 Feb; 54(2):265-74. PubMed ID: 2578429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.
    Chehimi J; Valiante NM; D'Andrea A; Rengaraju M; Rosado Z; Kobayashi M; Perussia B; Wolf SF; Starr SE; Trinchieri G
    Eur J Immunol; 1993 Aug; 23(8):1826-30. PubMed ID: 8102101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor.
    Mingari MC; Vitale C; Cantoni C; Bellomo R; Ponte M; Schiavetti F; Bertone S; Moretta A; Moretta L
    Eur J Immunol; 1997 Jun; 27(6):1374-80. PubMed ID: 9209487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.